A study of evaluating Perindopril treatment adherence based on Therapeutic drug monitoring and pharmacokinetic simulations.
Phase of Trial: Phase IV
Latest Information Update: 11 Dec 2017
At a glance
- Drugs Ranibizumab (Primary)
- Indications Choroidal neovascularisation
- Focus Adverse reactions; Therapeutic Use
- Acronyms PIXEL
- Sponsors Novartis Pharma
- 11 Dec 2017 New trial record.